VIST vs. TVTX
VIST (Vista Oil & Gas, S.A.B. de C.V.) and TVTX (Travere Therapeutics, Inc.) are both stocks. VIST operates in Oil & Gas E&P (Energy), while TVTX operates in Biotechnology (Healthcare). Over the past 5 years, VIST returned 79.67%/yr vs 25.91%/yr for TVTX. At a 0.11 correlation, their price movements are largely independent.
Performance
VIST vs. TVTX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VIST achieves a 51.99% return, which is significantly higher than TVTX's 23.21% return.
VIST
- 1D
- -0.62%
- 1M
- 13.42%
- YTD
- 51.99%
- 6M
- 45.30%
- 1Y
- 47.89%
- 3Y*
- 46.82%
- 5Y*
- 79.67%
- 10Y*
- —
TVTX
- 1D
- 2.77%
- 1M
- 10.52%
- YTD
- 23.21%
- 6M
- 37.30%
- 1Y
- 207.31%
- 3Y*
- 41.35%
- 5Y*
- 25.91%
- 10Y*
- 10.47%
VIST vs. TVTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
VIST Vista Oil & Gas, S.A.B. de C.V. | 51.99% | -10.07% | 83.36% | 88.44% | 193.81% | 108.20% | -67.39% | -13.74% |
TVTX Travere Therapeutics, Inc. | 23.21% | 119.35% | 93.77% | -57.25% | -32.25% | 13.89% | 91.94% | -31.40% |
Correlation
The correlation between VIST and TVTX is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.04 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Jul 29, 2019 | 0.11 |
Fundamentals
VIST:
$8.15B
TVTX:
$4.33B
VIST:
$6.82
TVTX:
-$0.49
VIST:
2.78
TVTX:
8.20
VIST:
3.14
TVTX:
43.81
VIST:
$2.90B
TVTX:
$536.20M
VIST:
$1.31B
TVTX:
$385.20M
VIST:
$2.12B
TVTX:
$11.15M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VIST vs. TVTX — Risk / Return Rank
VIST
TVTX
VIST vs. TVTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Vista Oil & Gas, S.A.B. de C.V. (VIST) and Travere Therapeutics, Inc. (TVTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| VIST | TVTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.95 | ||
| Sortino ratioReturn per unit of downside risk | -2.20 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.48 | -0.28 |
| Calmar ratioReturn relative to maximum drawdown | 1.32 | 6.23 | -4.91 |
| Martin ratioReturn relative to average drawdown | 3.01 | 14.39 | -11.39 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| VIST | TVTX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.97 | 2.92 | -1.95 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 1.54 | 0.39 | +1.15 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.18 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.59 | 0.30 | +0.29 |
Drawdowns
VIST vs. TVTX - Drawdown Comparison
The maximum VIST drawdown since its inception was -81.19%, roughly equal to the maximum TVTX drawdown of -85.43%. Use the drawdown chart below to compare losses from any high point for VIST and TVTX.
Loading charts...
Drawdown Indicators
| VIST | TVTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -81.19% | -85.43% | +4.24% |
Max Drawdown (1Y)Largest decline over 1 year | -36.48% | -33.49% | -2.99% |
Max Drawdown (3Y)Largest decline over 3 years | -43.36% | -69.77% | +26.41% |
Max Drawdown (5Y)Largest decline over 5 years | -43.36% | -83.12% | +39.76% |
Max Drawdown (10Y)Largest decline over 10 years | — | -83.64% | — |
Current DrawdownCurrent decline from peak | -6.68% | -1.42% | -5.26% |
Average DrawdownAverage peak-to-trough decline | -28.28% | -41.13% | +12.85% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.98% | 14.49% | +1.49% |
Volatility
VIST vs. TVTX - Volatility Comparison
The current volatility for Vista Oil & Gas, S.A.B. de C.V. (VIST) is 12.78%, while Travere Therapeutics, Inc. (TVTX) has a volatility of 14.17%. This indicates that VIST experiences smaller price fluctuations and is considered to be less risky than TVTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VIST | TVTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.78% | 14.17% | -1.39% |
Volatility (6M)Calculated over the trailing 6-month period | 32.62% | 51.90% | -19.28% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.84% | 71.68% | -21.84% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 52.04% | 66.44% | -14.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 61.06% | 58.34% | +2.72% |
Dividends
VIST vs. TVTX - Dividend Comparison
Neither VIST nor TVTX has paid dividends to shareholders.
Financials
VIST vs. TVTX - Financials Comparison
This section allows you to compare key financial metrics between Vista Oil & Gas, S.A.B. de C.V. and Travere Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
VIST vs. TVTX - Profitability Comparison
VIST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Vista Oil & Gas, S.A.B. de C.V. reported a gross profit of 472.36M and revenue of 865.01M. Therefore, the gross margin over that period was 54.6%.
TVTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Travere Therapeutics, Inc. reported a gross profit of 0.00 and revenue of 127.20M. Therefore, the gross margin over that period was 0.0%.
VIST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Vista Oil & Gas, S.A.B. de C.V. reported an operating income of 216.12M and revenue of 865.01M, resulting in an operating margin of 25.0%.
TVTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Travere Therapeutics, Inc. reported an operating income of -36.60M and revenue of 127.20M, resulting in an operating margin of -28.8%.
VIST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Vista Oil & Gas, S.A.B. de C.V. reported a net income of 107.71M and revenue of 865.01M, resulting in a net margin of 12.5%.
TVTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Travere Therapeutics, Inc. reported a net income of -37.10M and revenue of 127.20M, resulting in a net margin of -29.2%.
Frequently Asked Questions
VIST and TVTX have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TVTX has higher volatility (14.17%) compared to VIST (12.78%). In terms of maximum drawdown, VIST dropped -81.19% vs TVTX's -85.43%.
TVTX currently has the higher Sharpe Ratio (2.92 vs 0.97), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VIST and TVTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer